Advertisement

Transgenic Research

, Volume 10, Issue 3, pp 269–275 | Cite as

Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart

  • Maria L. Valencik
  • John A. McDonald
Article

Abstract

Tetracycline regulated gene expression in transgenic animals is potentially a very powerful technique (Furth et al., 1994; Gossen & Bujard 1992). We have utilized this system in an attempt to overcome the perinatal lethality resulting from constitutive transgenic expression in the heart (Valencik & McDonald, Am J Physiol Heart Circ Physiol 280: H361–H367). We found that compound hemizygous animals created by mating selected reverse tetracycline transactivator (rtTA) and transresponder (TR) lines display tightly regulated TR expression in the heart. However, we identified two fundamental problems. First, codon usage bias appeared to severely limit the expression of the rtTA driven by the cardiac α-myosin heavy chain promoter. Second, co-injection of rtTA and TR transgenes led to compound hemizygous animals that exhibited unregulated TR gene expression. Codon optimization of the rtTA construct leads to marked improvement (increasing the average induction from 20-fold to 832-fold) in cardiac myocyte expression. The resulting opt-rtTA lines can be bred to homozygosity, facilitating rapid screening of F0 TR animals for doxycycline regulated transgene expression.

conditional transgene expression doxycycline heart tetracycline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baron U, Freundlieb S, Gossen M and Bujard H (1995) Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23: 3605–3606.Google Scholar
  2. Bowman JC, Steinberg SF, Jiang T, Geenen DL, Fishman GI and Buttrick PM (1997) Expression of protein kinase Cβ in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest 100: 2189–2195.Google Scholar
  3. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A et al. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91: 9302–9306.Google Scholar
  4. Gordon JW (1993) Production of transgenic mice. Meth Enzymol 225: 747–771.Google Scholar
  5. Gossen M and Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547–5551.Google Scholar
  6. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W and Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766–1769.Google Scholar
  7. Gulick J, Subramaniam A, Neumann J and Robbins J (1991) Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 266: 9180–9185.Google Scholar
  8. LaFlamme SE, Thomas LA, Yamada SS and Yamada KM (1994) Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly. J Cell Biol 126: 1287–1298.Google Scholar
  9. Malumbres M, Mangues R, Ferrer N, Lu S and Pellicer A (1997) Isolation of high molecular weight DNA for reliable genotyping of transgenic mice. Biotechniques 22: 1114–1119.Google Scholar
  10. Rossant J and McMahon A (1999) ‘Cre’-ating mouse mutants—a meeting review on conditional mouse genetics. Genes Dev 13: 142–145.Google Scholar
  11. Schreiner CL, Bauer JS, YND, Hussein S, Sczekan MM and Juliano RL (1989) Isolation and characterization of chinese hamster ovary cell variants deficient in the expression of fibronectin receptor. J Cell Biol 109: 3157–3167.Google Scholar
  12. Van-Nhieu GT and Isberg RR (1991) The Yersinia pseudotuberculosis invasin protein and human fibronectin bind to mutually exclusive sites on the α5β1 integrin receptor. J Biol Chem 266: 24376–24375.Google Scholar
  13. Wells KD, Foster JA, Moore K, Pursel VG and Wall RJ (1999) Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch. Transgenic Res 8: 371–381.Google Scholar
  14. White JH, Brou C, Wu J, Burton N, Egly JMand Chambon P (1991) Evidence for a factor required for transcriptional stimulation by the chimeric acidic activator GAL-VP16 in HeLa cell extracts. Proc Natl Acad Sci USA 88: 7674–7678.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Maria L. Valencik
    • 1
  • John A. McDonald
    • 1
  1. 1.Department of Biochemistry and Molecular Biology, Samuel C. Johnson Medical Research Building Sj2-261Mayo Clinic ScottsdaleScottsdaleUSA

Personalised recommendations